Pfizer Inc (NYSE:PFE)
| 28.91 Delayed Data As of Dec 01 |  -1.56 / -5.14%Today’s Change | 28.30 Today|||52-Week Range 54.93 | -43.59% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | 7.0B | 7.2B | 21.4B | 11.2B | |
| Depreciation | 5.2B | 5.8B | 6.3B | 6.4B | ||
| Total Other Cash Flow | 1.8B | 3.5B | -10.0B | 1.4B | ||
| Funds From Operations | 13.9B | 15.8B | 15.2B | 16.8B | ||
| Extraordinary Items | 6.0M | 0.00 | 0.00 | 0.00 | ||
| Funds From/For Other Operating Expenses | -564.0M | -85.0M | -1.3B | 927.0M | ||
| Net Cash Flow - Operating Activities | 14.5B | 15.9B | 16.5B | 15.8B | ||
| Investing | Increase In Investments | -38.1B | -28.2B | -18.1B | -17.4B | |
| Decrease In Investments | 52.8B | 40.7B | 16.0B | 23.8B | ||
| Capital Expenditures | -1.4B | -1.8B | -2.0B | -2.0B | ||
| Net Assets From Acquisitions | -16.5B | -18.4B | -1.0B | 0.00 | ||
| Other Investing - Uses | -1.0M | 0.00 | 0.00 | 0.00 | ||
| Other Investing - Sources | 344.0M | 52.0M | 650.0M | 287.0M | ||
| Net Cash Flow Investing | -3.0B | -7.8B | -4.7B | 4.5B | ||
| Financing | Short Term Borrowings | 4.3B | -714.0M | -125.0M | -2.3B | |
| Long Term Borrowings | 0.00 | 11.0B | 5.3B | 5.0B | ||
| Long Term Debt Reduction | -3.0B | -7.7B | -6.2B | -3.6B | ||
| Net Proceeds Stock Sale | 1.3B | 1.0B | 862.0M | 1.3B | ||
| Common Preferred Redeemed | -6.2B | -5.0B | -5.0B | -12.2B | ||
| Common Dividends | -6.9B | -7.3B | -7.7B | -8.0B | ||
| Cash Dividends Paid - Total | -6.9B | -7.3B | -7.7B | -8.0B | ||
| Other Sources - Financing | 298.0M | 0.00 | 0.00 | 0.00 | ||
| Other Uses - Financing | 0.00 | 196.0M | 233.0M | 589.0M | ||
| Net Cash Flow - Financing | -10.2B | -8.9B | -13.0B | -20.4B | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -1.0B | -215.0M | 53.0M | -116.0M | |
| Net Change In Cash | 1.3B | -831.0M | -1.3B | -89.0M | ||
